RSV Antibody Treatment Effective For Babies
TUESDAY, May 6, 2025 (HealthDay News) — Newborns can be effectively protected against respiratory syncytial virus (RSV) infection through the use of nirsevimab, a monoclonal antibody treatment, researchers report. Babies treated with nirsevimab had an 83% reduced risk of hospitalization due to RSV infection, researchers reported May 1 in TheContinue Reading